AdaptVac ApS: Financial statements 2022
CVR: 38732730
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
AdaptVac ApS (CVR 38732730) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -1,581,922 and a net result of DKK -4,794,662 compared with DKK -1,781,825 the year before. Equity in the 2022 report amounted to DKK 7,762,092. The solvency ratio was 55.4%. The company had 6 employees in the financial year.
- Gross Profit
- DKK -1,581,922
- Profit/Loss
- DKK -4,794,662
- Equity
- DKK 7,762,092
- Total Assets
- DKK 14,014,991
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -1.6 mio. | -4.8 mio. | 7.8 mio. | 6 |
| 2021 | - | 1.3 mio. | -1.8 mio. | 12.6 mio. | 5 |
| 2020 | - | 20.2 mio. | 15.5 mio. | 15.3 mio. | 3 |
| 2019 | - | 1.4 mio. | -185 t. | -122 t. | 3 |
| 2018 | - | 432 t. | 334 t. | 64 t. | 0 |
Official annual report
Keep an eye on AdaptVac ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
AdaptVac ApS has published its annual report for 2021. Gross profit came to DKK 1,330,522, and the net result was DKK -1,781,825.
As of May 5, 2022, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of AdaptVac ApS.
About AdaptVac ApS
AdaptVac ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Willem Adriaan De Jongh and Adam Frederik Sander Bertelsen. The board consists of Morten Agertoug Nielsen (chair), Adam Frederik Sander Bertelsen, Ali El-Salanti and Jacob Hjulmand. The company is owned by EXPRES2ION BIOTECHNOLOGIES ApS and NextGen Vaccines Holding ApS. According to the 2025 annual report, the company had an average of 7 employees. In 2025, the company reported a gross profit of DKK -3,160,505 and a net result of DKK -7,053,665 compared with DKK 1,714,349 the year before. Equity in the 2025 report amounted to DKK 10,808,696.